阻塞性睡眠呼吸暂停低通气综合征与高血压之间关系的研究进展

摘要/Abstract

摘要：

【摘要】阻塞性睡眠呼吸暂停低通气综合征与高血压关系密切，可能是某些继发性高血压的主要病因之一，对合并阻塞性睡眠呼吸暂停低通气综合征的高血压患者采取综合性治疗对控制高血压及心脑血管病可能有益处。

文章导读： 本文对阻塞性睡眠呼吸暂停低通气综合征与高血压的关系及可能机制做了详细阐述，对合并阻塞性睡眠呼吸暂停低通气综合征的高血压患者进行综合治疗对控制血压及心脑血管疾病可能有益。

Abstract:

【Abstract】 Obstructive sleep apnea hypopnea syndrome (OSAHS) is closely associated with hypertension. It is one of the leading causes for some secondary hypertension. The comprehensive treatment is possibly good for the control of hypertension and cardiovascular and cerebrovascular disease in patients with OSAHS and hypertension.

Key words: Hypertension; Obstructive sleep apnea hypopnea syndrome; Ambulatory blood pressure

于逢春，周正宏. 阻塞性睡眠呼吸暂停低通气综合征与高血压之间关系的研究进展[J]. 中国卒中杂志, 2013, 8(09): 730-734.

YU Feng-Chun, ZHOU Zheng-Hong. Advance in Research of the Relationship between Obstructive Sleep Apnea Hypopnea Syndrome and Hypertension[J]. Chinese Journal of Stroke, 2013, 8(09): 730-734.

参考文献

1 中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J]. 中华结核和呼吸杂志, 2012, 35:9-12.

2 Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality:a prospective cohort study[J]. PLoS Med, 2009, 6:e1000132.

3 Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death[J]. N Engl J Med, 2005, 353:2034-2041.

4 Kohler M, Strading JR. Mechanisms of vascular damage in obstructive sleep apnea[J]. Nat Rev Cardiol, 2010, 7:677-685.

5 Punjabi NM. The epidemiology of adult obstructive sleep apnea[J]. Proc Am Thorac Soc, 2008, 5:136-143.

6 Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease:an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)[J]. Circulation, 2008, 118:1080-1111.

7 Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders as a major cause of essential hypertension:fact or fiction?[J]. Curr Opin Nephrol Hypertens, 1998, 7:353-357.

8 Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study[J]. JAMA, 2000, 283:1829-1836.

9 Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension[J]. Arch Intern Med, 1997, 157:1746-1752.

10 Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension[J]. N Engl J Med, 2000, 342:1378-1384.

11 李南方, 林丽, 王磊, 等. 1999-2008年高血压专科住院患者病因构成的分析[J]. 中华高血压杂志, 2011, 19:939-942.

12 Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension[J]. J Hypertens, 1997, 15:1227-1233.

13 Hla KM, Young T, Finn L, et al. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study[J]. Sleep, 2008, 31:795-800.

14 Lloberes P, Lozano L, Sampol G, et al. Obstructive sleep apnea and 24-h blood pressure in patients with resistant hypertension[J]. J Sleep Res, 2010, 19:597-602.

15 Chokroverty S. Sleep disorders medicine[M]. 3rd ed. Philadephia:Elsevier Inc. 2009:92-105.

16 Fletcher EC, Miller J, Schaaf JW, et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension[J]. Sleep, 1987, 10:35-44.

17 Fletcher EC, Lesske J, Qian W, et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats[J]. Hypertension, 1992, 19:555-561.

18 Lombardi C, Parati G, Cortelli P, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders[J]. J Sleep Res, 2008, 17:263-270.

19 Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea[J]. Am J Hypertens, 2003, 16:274-280.

20 Foster GE, Hanly PJ, Ahmed SB, et al. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism[J]. Hypertension, 2010, 56:369-377.

21 Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats[J]. Circ Res, 1994, 74:416-421.

22 Suzuki YJ, Jain V, Park AM, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases[J]. Free Radic Bio Med, 2006, 40:1683-1692.

23 Mohsenin V, Urbano F. Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension[J]. Respir Med, 2011, 105:801-807.

24 Noda A, Nakata S, Koike Y, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome[J]. Hypertens Res, 2007, 30:669-676.

25 Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment[J]. Am J Respir Crit Care Med, 2004, 169:348-353.

26 Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnea/hypopnea syndrome:a randomised controlled trial[J]. Thorax, 2008, 63:578-583.

27 Lurbe E, Torro I, Aguilar F, et al. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents[J]. Hypertension, 2008, 51:635-641.

28 Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance:the Sleep Heart Health Study[J]. Am J Epidemiol, 2004, 160:521-530.

29 Lam JC, Mak JC, Ip MS, et al. Obesity, obstructive sleep apnea and metabolic syndrome[J]. Respirology, 2012, 17:223-236.

30 Riha RL, Diefenbach K, Jennum P, et al. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnea-hypopnea syndrome[J]. Sleep Med Rev, 2008, 2:49-63.

31 Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension[J]. JAMA, 2012, 307:2169-2176.

32 Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension:joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea[J]. J Hypertens, 2012, 30:633-646.

33 Börgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs[J]. Am J Hypertens, 2004, 17:1081-1087.

34 Ziegler MG, Milic M, Sun P. Antihypertensive therapy for patients with obstructive sleep apnea[J]. Curr Opin Nephrol Hypertens, 2011, 20:50-55.

35 Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension:a preliminary report[J]. J Hum Hypertens, 2010, 24:532-537.

[1]	宋彦丽, 林杰, 武一平, 李晓晶, 刘改芬, 夏文静, 张玉英, 张晓林, 吕晨冉, 周红, 李凯, 薛斌, 陈玲玲, 张忠波, 彭晓. 邯郸市居民心脑血管病危险因素的流行现状及高血压知晓率、治疗率和控制率的影响因素研究 [J]. 中国卒中杂志, 2022, 17(12): 1360-1365.
[2]	郑占军, 赵性泉. 脑小血管病影像学标志物与自发性高血压脑出血的相关性研究进展[J]. 中国卒中杂志, 2022, 17(12): 1396-1402.
[3]	朱翠婷, 胡文立. 头晕/眩晕患者脑小血管病总负荷的危险因素分析[J]. 中国卒中杂志, 2022, 17(04): 354-359.
[4]	孔芳, 黄旭, 魏廉, 赵义. 以缺血性卒中发病的大动脉炎15例临床特点分析[J]. 中国卒中杂志, 2021, 16(12): 1210-1216.
[5]	陈政宇, 陈国芳, 陈彤, 马冬娇. 急性缺血性卒中静脉溶栓患者不同部位脑白质疏松的影响因素分析[J]. 中国卒中杂志, 2021, 16(12): 1248-1252.
[6]	曹双双, 张晓燕, 王建伟, 赵磊, 陈红兵, 汪明玉. 急性缺血性卒中静脉溶栓后早期神经功能恶化影响因素分析[J]. 中国卒中杂志, 2021, 16(12): 1253-1258.
[7]	樊华声，魏风，钟仕茂，胡北泉，杨松，刘海峰，吴静. 高血压脑出血后T淋巴细胞亚群的动态变化[J]. 中国卒中杂志, 2021, 16(03): 283-287.
[8]	宋彦丽，林杰，夏文静，薛斌，武一平. 同型半胱氨酸与高血压患者轻度认知障碍的相关性[J]. 中国卒中杂志, 2020, 15(12): 1322-1326.
[9]	郑华光，刘晓楠，张蔚韡，张龙友，王瑞青，孟庆颖，段芸芸，刘亚欧，王拥军. 高血压和高同型半胱氨酸血症与静止性脑梗死的相关性分析[J]. 中国卒中杂志, 2020, 15(08): 861-868.
[10]	嵇朋，江利敏，孙根，寇启星，屈雪萍，孙雅静，孟凡超，周衡. 急性缺血性卒中患者阻塞性睡眠呼吸暂停低通气综合征与相关血液生化标志物的临床研究[J]. 中国卒中杂志, 2020, 15(05): 550-554.
[11]	姚明，周立新，朱以诚，彭斌，倪俊. CADASIL患者脑微出血分布特征及临床意义[J]. 中国卒中杂志, 2020, 15(04): 343-348.
[12]	何倩倩，伏兵，张照婷，李敏，董万利. H型高血压患者脑白质病变和脑血流动力学的特点[J]. 中国卒中杂志, 2020, 15(01): 22-27.
[13]	唐欣颖, 匡泽民, 卢玺峰. 中枢神经系统肾素（原）受体参与高血压发病机制的研究进展[J]. 中国卒中杂志, 2019, 14(12): 1279-1282.
[14]	王伊龙，韩尚容，曹勇，等，中国卒中学会中国脑血管病临床管理指南撰写委员会（*第一作者）. 中国脑血管病临床管理指南（节选版）—— 脑血管病高危人群管理[J]. 中国卒中杂志, 2019, 14(07): 700-708.
[15]	傅翔，李洁，刘昱璐，吴嘉靖，刘春风. 阻塞性睡眠呼吸暂停低通气综合征与醒后卒中之间关系的研究进展[J]. 中国卒中杂志, 2019, 14(04): 352-356.